Company: NMP
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001213900-25-075714
Chunk: 21

Company: NMP Acquisition Corp.
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 1
Chunk 21
---
 are due
on the date in which the Company consummates its initial Business Combination or on the date of its dissolution deadline, assuming there
is cash available. At the closing of the Initial Public Offering, $150,000 of the outstanding principal balance of these loans will be
deemed to be repaid and settled in connection with the Sponsor’s purchase of Private Placement Units at a price of $10.00 per unit
(such deemed repayment being attributed to the purchase of 15,000 Private Placement Units by the Sponsor) (see Note 4). As of June 30,
2025 and December 31, 2024, the Company drew an aggregate of $155,093 and $30,300, respectively, against the promissory note. Outstanding
amounts under this loan may be repaid upon the closing of the Company’s initial Business Combination out of the proceeds of the
Initial Public Offering and sale of the Private Placement Units not held in the Trust Account.

Advances from Sponsor

As of December 31, 2024,
the Sponsor advanced $25,000 which has been allocated to the purchase of the Sponsor’s Founder Shares. This advance was used for
the purchase of the Sponsor’s Founder Shares pursuant to that certain Founder Share Subscription Agreement, dated January 13, 2025,
between the Company and the Sponsor, on such date. As of June 30, 2025 there were no advances from Sponsor remaining except for the amount
advanced for the Private Placement Units as described in Note 6.

NOTE 6 — ADVANCES FROM INVESTORS

As of June 30, 2025, the
Company received advance payments of $975,000 from the Sponsor and $285,000 from the Maxim individuals for the purchase of Private Placement
Units in connection with the Initial Public Offering that closed on July 2, 2025 and the exercise of the underwriters’ over-allotment
that closed on July 10, 2025. The investments were recorded in payables as of June 30, 2025 and settled simultaneously with the Initial
Public Offering on July 2, 2025 and the exercise of the underwriters’ over-allotment on July 10, 2025. 

NOTE 7 — COMMITMENTS AND CONTINGENCIES

Registration Rights

The holders of the Founder
Shares, Representative Shares and Private Placement Units (and the securities comprising such units, as applicable, and any Class
A ordinary shares iss